10x Science Raises $4.8M Seed
Oversubscribed seed led by Initialized Capital; AI-native protein characterization platform; YC W26 company.
Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:16 PM
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
10x Science AI-native protein characterization for drug development.
Raised $4.8M across 1 funding round. Latest: $4.8M Seed (Apr 2026). Investors: Initialized Capital, Y Combinator, Civilization Ventures, Founder Factor. (Medium).
Seed (YC)
Verified facts
+1 more in Recent movement below
Funding
Raised $4.8M across 1 funding round. Latest: $4.8M Seed (Apr 2026). Investors: Initialized Capital, Y Combinator, Civilization Ventures, Founder Factor. (Medium).
Hiring
2 hiring‑related row(s); role‑spam risk if mostly generic boards (High).
GitHub
No GitHub‑linked evidence indexed (Low).
Product / news
5 product/news‑styled row(s); headline risk without filings (High).
Traffic / social
No traffic/social evidence indexed (Low).
Oversubscribed seed led by Initialized Capital; AI-native protein characterization platform; YC W26 company.
No open roles indexed yet.
No failed or blocked source links on record.
The score is an algorithmic estimate based on observed public company-level signals. It may be incomplete, stale, or inaccurate and is not investment, legal, tax, or business advice.
DealFlow score momentum
More runs will build history.
The score is an algorithmic estimate based on observed public company-level signals. It may be incomplete, stale, or inaccurate and is not investment, legal, tax, or business advice.
Latest momentum signal per category. Expand a card to inspect raw payloads.
Source types found
Strongest / recent news-style rows
10x Science | Y Combinator
Wed, May 20, 06:16 PM · confidence 85%high quality
https://www.ycombinator.com/companies/10x-science10x Science: AI-Native Software for Scientists
About / company · Mon, May 11, 04:47 AM · confidence 70%high quality
https://10xscience.com/company10x Science: AI-Native Software for Scientists
About / company · Mon, May 11, 04:47 AM · confidence 70%high quality
https://10xscience.com/aboutNewest first · 10 event(s)
Founders from Carolyn Bertozzi's Stanford lab; W26 batch.
AI-native protein characterization for drug development.
Source: Blog / news
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
Source: Blog / news
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
Source: Careers
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
Source: About / company
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
Source: Careers
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
Source: Blog / news
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
Source: About / company
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
Oversubscribed seed led by Initialized Capital; AI-native protein characterization platform; YC W26 company.
1 row(s)
AI-native protein characterization for drug development.
https://10xscience.com/3 row(s)
Founders from Carolyn Bertozzi's Stanford lab; W26 batch.
https://www.ycombinator.com/companies/10x-scienceSource name: About / company
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
https://10xscience.com/companySource name: About / company
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
https://10xscience.com/about1 row(s)
Oversubscribed seed led by Initialized Capital; AI-native protein characterization platform; YC W26 company.
https://www.prnewswire.com/news-releases/10x-science-raises-4-8m-seed-to-build-ai-that-understands-proteins-at-the-molecular-level-302750622.html2 row(s)
Source name: Careers
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
https://10xscience.com/jobsSource name: Careers
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
https://10xscience.com/careers3 row(s)
Source name: Blog / news
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
https://10xscience.com/pressSource name: Blog / news
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
https://10xscience.com/newsSource name: Blog / news
Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.
https://10xscience.com/blogSign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.